Valeant Stock Tumbles on $750 Million Debt Offering Announcement
In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018.

Valeant Pharmaceuticals Int'l Inc. (VRX) shares dipped 1.63% to $15.13 in mid-morning trading Monday, Nov. 13, after the drug maker launched a $750 million debt offering.

Valeant announced the private offering with notes due in 2025 in a statement Monday. The proceeds from the offering of the existing 5.5% senior secured notes will be used to repay a portion of term loan facilities due in 2022, Valeant said.

In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018. Valeant still has more than $26 billion in debt, but no obligations until 2020.

Valeant stock has gained 4.27% since the start of the year, compared to the broader S&P 500 Index's 15.3% gain in the same period.

More of What's Trending on TheStreet:

More from Stocks

Stocks Trade Mixed, Nasdaq Posts Early Gains

Stocks Trade Mixed, Nasdaq Posts Early Gains

JPMorgan and Oracle Jump After Warren Buffett Buys Shares

JPMorgan and Oracle Jump After Warren Buffett Buys Shares

Walmart Stock Mixed After Q3 Results, Increased Guidance

Walmart Stock Mixed After Q3 Results, Increased Guidance

Aggressive Traders Might Put SurveyMonkey Parent SVMK on Their Watch List

Aggressive Traders Might Put SurveyMonkey Parent SVMK on Their Watch List

Cisco, Walmart, Brexit, Warren Buffett and JPMorgan - 5 Things You Must Know

Cisco, Walmart, Brexit, Warren Buffett and JPMorgan - 5 Things You Must Know